T. Rowe Price Associates’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $181M | Sell |
|
|||||
|
2025
Q2 | $241M | Sell |
|
|||||
|
2025
Q1 | $195M | Buy |
|
|||||
|
2024
Q4 | $120M | Buy |
|
|||||
|
2024
Q3 | $109M | Sell |
|
|||||
|
2024
Q2 | $97.3M | Buy |
|
|||||
|
2024
Q1 | $103M | Buy |
|
|||||
|
2023
Q4 | $85.8M | Sell |
|
|||||
|
2023
Q3 | $193M | Buy |
|
|||||
|
2023
Q2 | $154M | Buy |
|
|||||
|
2023
Q1 | $100M | Buy |
|
|||||
|
2022
Q4 | $132M | Buy |
|
|||||
|
2022
Q3 | $49.8M | Buy |
|
|||||
|
2022
Q2 | $4.3M | Sell |
|
|||||
|
2022
Q1 | $6.46M | Sell |
|
|||||
|
2021
Q4 | $24.5M | Buy |
|
|||||
|
2021
Q3 | $25.7M | Sell |
|
|||||
|
2021
Q2 | $28.6M | Buy |
|
|||||
|
2021
Q1 | $25.9M | Buy |
|
|||||
|
2020
Q4 | $17M | Buy |
|
|||||
|
2020
Q3 | $15.5M | Buy |
|
|||||
|
2020
Q2 | $3.65M | Sell |
|
|||||
|
2020
Q1 | $5.08M | Buy |
|
|||||
|
2019
Q4 | $5.03M | Buy |
|
|||||
|
2019
Q3 | $4.64M | Buy |
|
|||||
|
2019
Q2 | $3.86M | Buy |
|